Amarin Corp Plc (AMRN): VAscepa ... the statin of Triglycerides...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	21
Posts	2539
Boards Moderated	0
Alias Born	12/07/2013

ralphey

Re: None

Friday, 03/06/2015 8:50:06 AM

Friday, March 06, 2015 8:50:06 AM

VAscepa ... the statin of Triglycerides -

Vascepa ... Your statins best friend

over one year ago I posted the ff on SA (http://seekingalpha.com/instablog/1077258-ralphey/3082365-amrn-sitting-on-a-gold-mine)

heres the issue:

The new standard for treatment and reduction of CAD will not just be statins - it will be a combo pill of a statin and EPA. Doctors will no longer just prescribe Lipitor or Crestor etc - they will prescribe them with EPA - AMRN captures nearly the entire statin market as an add on to every statin ! This is monstrous . The statin market can be estimated to be 35 billion worldwide. Lets say VASCEPA only captures ¼ of the new combo market - roughly 9 billion dollars of it. The company is currently burning 80 million per year . Quadruple or quintuple those expenses , that still leaves a potential of 8.5 billion per year on 180 million shares - of course that makes the stock invaluable.